MRI Analysis in the Growth of Cerebral Aneurysms

Launched by CHU DE REIMS · Nov 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying unruptured intracranial aneurysms, which are balloon-like swellings in the blood vessels of the brain that have not yet burst. The goal is to use MRI scans, a safe and non-invasive imaging method, to better understand how these aneurysms grow and to find markers that could help predict the risk of future aneurysm development. This research aims to improve monitoring and treatment options for people with these conditions.

To participate in the trial, you need to be over 18 years old and have at least one unruptured intracranial aneurysm, which is being monitored at the study center. You also need to be enrolled in the national healthcare insurance program and agree to take part in the study. However, if you've had surgery for your aneurysms or are scheduled for treatment soon, or if you have certain medical conditions, you may not be eligible. If you join the study, you can expect to undergo MRI scans to help researchers gather important information about your condition.

Gender

ALL

Eligibility criteria

• inclusion criteria:
• • Patients with one or more unruptured intracranial aneurysms followed up at the participating center. Patients may have other ruptured and/or treated aneurysms
• • Patient older than 18 years
• • Patient consenting to participate to the study
• • Patient enrolled in the national healthcare insurance program
• exclusion criteria:
• • Patients who have already received surgical or endovascular treatment for all their aneurysm(s), or who are due to receive such treatment in less than 2 months.
• • Patients with only ruptured aneurysm(s)
• • Patients with arteriovenous malformations (treated or untreated)
• • Patients with a contraindication to MRI
• • Patients with an allergy to one of the contrast agents (Iodixanol, Gadoteric acid)
• • Pregnant or breast-feeding patients
• • Patients protected by law.